Study Objectives To evaluate if semaglutide 2.4 mg subcutaneously once weekly is superior to placebo when added to standard of care for preventing major adverse cardiovascular events in patients with established CVD and overweight or obesity but without diabetes
Additionally, some report better recuperation and increased motivation to continue exercising
Quick Answer: Most patients taking GLP-1 medications can safely continue therapy before colonoscopy with a 24-hour liquid diet and individualized risk assessment, though some higher-risk patients may benefit from temporary medication holds
Ditch the all or nothing thinking All-or-nothing thinking, sometimes referred to as black-and-white thinking, is a tendency to see things as good/bad or either/or, with nothing in between
Our injectors develop individualized strategies that prioritize balance, proportion, and natural-looking outcomes
Zhang W, Xiang Q, Zhao J, et al